BioCentury
ARTICLE | Company News

CFIUS gives Novartis, Endocyte deal a pass -- for now

December 21, 2018 8:46 PM UTC

A Dec. 14 decision by CFIUS to neither clear nor initiate review of the $2.1 billion acquisition of Endocyte Inc. (NASDAQ:ECYT) by Novartis AG (NYSE:NVS; SIX:NOVN) provides little clarity as to how far the committee will tread into biotech territory.

The deal closed a week later...

BCIQ Company Profiles

Endocyte Inc.

Novartis AG